News

Researchers Jason Sello, PhD, Jarret Weinrich, PhD, and Matthew McCarroll PhD, are working to develop a new generation of anesthetics that are significantly safer and more stable.

Charles Craik, PhD, and his colleague Anthony O’Donoghue, his former postdoc, help as many researchers as they can with a new tool they developed for analyzing enzyme activity. To meet the growing demand, they realized the technology needed a home beyond academia and founded Alaunus Biosciences.

James Fraser, PhD, Brian Shoichet, PhD, and Balyn Zaro, PhD, have all been selected to join the Collaborative Research Network (CRN), an international consortium supported by Aligning Science Across Parkinson's (ASAP) in partnership with The Michael J. Fox Foundation for Parkinson's Research that aims to better understand Parkinson's disease and speed the development of future treatments. 

Postdoctoral scholars, specialists, and researchers (PSRs) from across the UCSF School of Pharmacy gathered at the Wayne and Gladys Valley Center for Vision on the Mission Bay campus on June 24, 2026, for the third annual PSR Symposium, an inspiring day of scientific exchange, career development, and community building hosted by the Center for Collaborative Innovation (CCI).

Researchers in the Department of Pharmaceutical Chemistry’s Altschuler-Wu Lab have developed a robotic platform capable of tracking and testing thousands of miniature tumors simultaneously, revealing shared weaknesses that could be exploited by future cancer therapies.

No single discovery is likely to cure Alzheimer's and related dementias, but Department of Pharmaceutical Chemistry Professors Charles Craik and Jason Gestwicki are making progress on multiple fronts, from detecting disease earlier to developing therapies that target the biological processes driving neurodegeneration.

A UCSF research team led by Department of Bioengineering and Therapeutic Sciences Chair and Professor James Fraser, PhD and Department of Pharmaceutical Chemistry Professor William DeGrado, PhD, has pioneered a breakthrough approach to designing proteins with targeted functions, which could lead to simpler ways to improve enzymes and medications, among other uses, according to a new study published in Nature Chemistry. 

Michelle Arkin, PhD, professor in the Department of Pharmaceutical Chemistry at the UCSF School of Pharmacy, has been elected to the American Academy of Arts and Sciences, one of the nation’s oldest and most influential learned societies.

Michelle Arkin, PhD, professor in the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry and a globally recognized scientist in drug discovery, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE)’s College of Fellows — one of the highest professional honors in the field.

Seven forward-thinking projects poised to advance the mission of the UCSF School of Pharmacy have been selected to receive support through the 2026 Mary Anne Koda-Kimble Seed Award for Innovation.

Researchers at UC San Francisco have discovered that the SRC enzyme appears like a flag on the surface of bladder, colorectal, breast, pancreatic, and probably many other tumor cells.

From designing smarter tuberculosis treatments to engineering new therapeutic proteins and decoding the genetic basis of disease, research at the UCSF School of Pharmacy is improving patient care and advancing medicine worldwide.

Aashish Manglik, MD, PhD, associate professor in the Department of Pharmaceutical Chemistry, has been awarded the Vilcek Prize for Creative Promise in recognition of his transformative work in cellular signaling.

At the UCSF School of Pharmacy, Bo Huang, PhD, a professor in the Department of Pharmaceutical Chemistry, is blending biological discovery with tool-building to reimagine how scientists visualize and understand life inside cells.

Three faculty members — John Irwin, PhD, Aashish Manglik, MD, PhD, and Brian Shoichet, PhD — are named in Clarivate’s 2025 list of Highly Cited Researchers, recognizing their scholarly impact and influence in their fields.

More than 100 current and former graduate students gathered on Oct. 3 for the School of Pharmacy’s first “Bridging Past and Future: Highlighting UCSF Graduate Students and Alumni” symposium.

UCSF School of Pharmacy drives biotech innovation with 44 startups and 64 patents that bridge basic research to therapies through bold entrepreneurship.

Department of Pharmaceutical Chemistry Professor Adam Renslo, PhD, is part of a team of UCSF chemists that has remodeled the structures of new malaria drugs to make them more soluble — while maintaining their effectiveness against drug-resistant parasites.